Business Description
Syngene International Ltd
ISIN : INE398R01022
Compare
Compare
Traded in other countries / regions
SYNGENE.India IPO Date
2015-08-11Description
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.81 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | 0.77 | |||||
| Interest Coverage | 19.4 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 10.41 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.4 | |||||
| 3-Year EBITDA Growth Rate | 8.4 | |||||
| 3-Year EPS without NRI Growth Rate | 9 | |||||
| 3-Year FCF Growth Rate | 106.9 | |||||
| 3-Year Book Growth Rate | 18.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.71 | |||||
| 9-Day RSI | 43.13 | |||||
| 14-Day RSI | 47.22 | |||||
| 6-1 Month Momentum % | -6.23 | |||||
| 12-1 Month Momentum % | 10.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.94 | |||||
| Quick Ratio | 1.68 | |||||
| Cash Ratio | 1.23 | |||||
| Days Inventory | 109.6 | |||||
| Days Sales Outstanding | 48.89 | |||||
| Days Payable | 92.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.07 | |||||
| Dividend Payout Ratio | 0.04 | |||||
| Forward Dividend Yield % | 0.07 | |||||
| 5-Year Yield-on-Cost % | 0.07 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 0.71 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.43 | |||||
| Operating Margin % | 19.1 | |||||
| Net Margin % | 14.48 | |||||
| FCF Margin % | 8.84 | |||||
| ROE % | 13.92 | |||||
| ROA % | 8.8 | |||||
| ROIC % | 12.1 | |||||
| ROC (Joel Greenblatt) % | 23.79 | |||||
| ROCE % | 14.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 60.16 | |||||
| PE Ratio without NRI | 59.33 | |||||
| Shiller PE Ratio | 63.8 | |||||
| Price-to-Owner-Earnings | 45.82 | |||||
| PEG Ratio | 5.07 | |||||
| PS Ratio | 8.71 | |||||
| PB Ratio | 7.69 | |||||
| Price-to-Tangible-Book | 7.32 | |||||
| Price-to-Free-Cash-Flow | 98.98 | |||||
| Price-to-Operating-Cash-Flow | 36.68 | |||||
| EV-to-EBIT | 40.91 | |||||
| EV-to-EBITDA | 25.47 | |||||
| EV-to-Revenue | 8.01 | |||||
| EV-to-FCF | 96.05 | |||||
| Price-to-Projected-FCF | 5.9 | |||||
| Price-to-DCF (Earnings Based) | 3.48 | |||||
| Price-to-DCF (FCF Based) | 3.93 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.98 | |||||
| Price-to-Graham-Number | 4.3 | |||||
| Price-to-Net-Current-Asset-Value | 67.43 | |||||
| Earnings Yield (Greenblatt) % | 2.45 | |||||
| FCF Yield % | 1.07 | |||||
| Forward Rate of Return (Yacktman) % | 12.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syngene International Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 34,534 | ||
| EPS (TTM) (₹) | 12.44 | ||
| Beta | 0.66 | ||
| Volatility % | 28.74 | ||
| 14-Day RSI | 47.22 | ||
| 14-Day ATR (₹) | 15.417801 | ||
| 20-Day SMA (₹) | 714.9325 | ||
| 12-1 Month Momentum % | 10.38 | ||
| 52-Week Range (₹) | 610.1 - 860.25 | ||
| Shares Outstanding (Mil) | 400.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syngene International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syngene International Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syngene International Ltd Frequently Asked Questions
What is Syngene International Ltd(NSE:SYNGENE)'s stock price today?
The current price of NSE:SYNGENE is ₹708.65. The 52 week high of NSE:SYNGENE is ₹860.25 and 52 week low is ₹610.10.
When is next earnings date of Syngene International Ltd(NSE:SYNGENE)?
The next earnings date of Syngene International Ltd(NSE:SYNGENE) is 2024-05-31 Est..
Does Syngene International Ltd(NSE:SYNGENE) pay dividends? If so, how much?
The Dividend Yield %  of Syngene International Ltd(NSE:SYNGENE) is 0.07% (As of Today), Highest Dividend Payout Ratio of Syngene International Ltd(NSE:SYNGENE) was 0.08. The lowest was 0.04. And the median was 0.06. The  Forward Dividend Yield % of Syngene International Ltd(NSE:SYNGENE) is 0.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers